- NCBI Gene Id:
- Protein Name:
- Alias Symbols:
- EDF, TRF, IL-5, IL5
- Replacement Item:
- This antibody may replace item sc-34812 from Santa Cruz Biotechnology.
- Description of Target:
- RABBIT ANTI HUMAN INTERLEUKIN-5
- Protein Size (# AA):
- ELISA, WB
- Tissue Tool:
- Find tissues and cell lines supported by DNA array analysis to express IL5.
- RNA Seq:
- Find tissues and cell lines supported by RNA-seq analysis to express IL5.
- The immunogen for anti-IL5 antibody: recombinant human IL-5
- Predicted Species Reactivity:
- Predicted Homology Based on Immunogen Sequence:
- Product Format:
- Purified IgG - lyophilised
- Reconstitution and Storage:
- Reconstitution: Reconstitute with 0.1ml distilled water. For long term storage the addition of 0.09% sodium azide is recommended. NB: For functional studies do not add azide.
Storage: Prior to reconstitution store at +4oC.
After reconstitution store at -20oC.
Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- Printable datasheet for anti-IL5 antibody - OASA07901
- Polyclonal IgG
- Application Info:
- ELISA : This antibody may be used in an indirect ELISA or as a capture reagent in a sandwich ELISA with This product B as the detection antibody
- Preservative Stabilisers: None present
Antiserum Preparation: Antisera to human IL-5 were raised by repeated immunisations of rabbits with highly purified antigen. Purified IgG prepared by affinity chromatography.
- Approx Protein Conc: IgG concentration 1.0mg/ml after reconstitution
Buffer Solutions: Phosphate buffered saline pH7.4
- Target Reference:
- 1. Campbell, H.D. et al. (1987) Molecular cloning, nucleotide sequence, and expression of the gene encoding human Eosinophil Differentiation Factor (Interleukin 5). P.N.A.S. 84: 6629-6633.
2. Wang, J. et al. (1998) Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J. Clin. Invest. 102: 1132-1141.